Head lice. Pediculosis due to Pediculus humanus capitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Conformity with head lice diagnostic criteria Age range between 18 and 65 years Signing informed consent Being in healthy condition Not using local or systemic anti-lice products during the recent infection
Exclusion criteria
Exclusion criteria: Local or systemic anti-lice treatment or use of hair dye during or before the study period Having serious diseases or extensive wounds, especially in the scalp area (such as impetigo or eczema), chronic scalp disorders (such as psoriasis, chronic dermatosis) and secondary scalp infection known allergy to any of the components of the product Treatment with antibiotics (cotrimoxazole, trimethoprim, tetracycline) or anthelmintics (such as ivermectin, levamisole, albendazole) in the last 1 month or other local or systemic drugs that may lead to errors in the test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lice levels. Timepoint: Before the initiation of intervention and the day after the last application of formulation. Method of measurement: Scoring the patients' symptoms based on a 0-10 Likert Scale with regard to improvements in symptoms (0=no improvement; 10= complete improvement). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before the start of the intervention and one day after the last use of the formulation. Method of measurement: Completion of a 30-question questionnaire on the quality of life of head lice patients by the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences